215 related articles for article (PubMed ID: 20943406)
1. Synthesis of new antifungal peptides selective against Cryptococcus neoformans.
Grimaldi M; De Rosa M; Di Marino S; Scrima M; Posteraro B; Sanguinetti M; Fadda G; Soriente A; D'Ursi AM
Bioorg Med Chem; 2010 Nov; 18(22):7985-90. PubMed ID: 20943406
[TBL] [Abstract][Full Text] [Related]
2. Antifungal peptides at membrane interaction.
Di Marino S; Scrima M; Grimaldi M; D'Errico G; Vitiello G; Sanguinetti M; De Rosa M; Soriente A; Novellino E; D'Ursi AM
Eur J Med Chem; 2012 May; 51():154-62. PubMed ID: 22417640
[TBL] [Abstract][Full Text] [Related]
3. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action.
Avrahami D; Shai Y
Biochemistry; 2003 Dec; 42(50):14946-56. PubMed ID: 14674771
[TBL] [Abstract][Full Text] [Related]
4. Fungicidal effect of three new synthetic cationic peptides against Candida albicans.
Nikawa H; Fukushima H; Makihira S; Hamada T; Samaranayake LP
Oral Dis; 2004 Jul; 10(4):221-8. PubMed ID: 15196144
[TBL] [Abstract][Full Text] [Related]
5. New antifungal peptides. Synthesis, bioassays and initial structure prediction by CD spectroscopy.
Olivella MS; Rodríguez AM; Zacchino SA; Somlai C; Penke B; Farkas V; Perczel A; Enriz RD
Bioorg Med Chem Lett; 2010 Aug; 20(16):4808-11. PubMed ID: 20620056
[TBL] [Abstract][Full Text] [Related]
6. Fungicide activity of 5-(4-chlorobenzylidene)-(Z)-2-dimethylamino-1,3-thiazol-4-one against Cryptococcus neoformans.
Insuasty B; Gutiérrez A; Quiroga J; Abonia R; Nogueras M; Cobo J; Svetaz L; Raimondi M; Zacchino S
Arch Pharm (Weinheim); 2010 Jan; 343(1):48-53. PubMed ID: 19927310
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel pyrazino[2,1-a]isoquinolin derivatives with potent antifungal activity.
Tang H; Zheng CH; Zhu J; Fu BY; Zhou YJ; Lv JG
Arch Pharm (Weinheim); 2010 Jun; 343(6):360-6. PubMed ID: 20232375
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis.
Wang H; Xu K; Liu L; Tan JP; Chen Y; Li Y; Fan W; Wei Z; Sheng J; Yang YY; Li L
Biomaterials; 2010 Apr; 31(10):2874-81. PubMed ID: 20044131
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship, conformational and biological studies of temporin L analogues.
Mangoni ML; Carotenuto A; Auriemma L; Saviello MR; Campiglia P; Gomez-Monterrey I; Malfi S; Marcellini L; Barra D; Novellino E; Grieco P
J Med Chem; 2011 Mar; 54(5):1298-307. PubMed ID: 21319749
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans.
Barchiesi F; Giacometti A; Cirioni O; Arzeni D; Silvestri C; Kamysz W; Abbruzzetti A; Riva A; Kamysz E; Scalise G
Peptides; 2007 Aug; 28(8):1509-13. PubMed ID: 17698253
[TBL] [Abstract][Full Text] [Related]
12. Effects of microplusin, a copper-chelating antimicrobial peptide, against Cryptococcus neoformans.
Silva FD; Rossi DC; Martinez LR; Frases S; Fonseca FL; Campos CB; Rodrigues ML; Nosanchuk JD; Daffre S
FEMS Microbiol Lett; 2011 Nov; 324(1):64-72. PubMed ID: 22092765
[TBL] [Abstract][Full Text] [Related]
13. Trivalent ultrashort lipopeptides are potent pH dependent antifungal agents.
Arnusch CJ; Albada HB; van Vaardegem M; Liskamp RM; Sahl HG; Shadkchan Y; Osherov N; Shai Y
J Med Chem; 2012 Feb; 55(3):1296-302. PubMed ID: 22243686
[TBL] [Abstract][Full Text] [Related]
14. Bulky 1,4-benzoxazine derivatives with antifungal activity.
Fringuelli R; Giacchè N; Milanese L; Cenci E; Macchiarulo A; Vecchiarelli A; Costantino G; Schiaffella F
Bioorg Med Chem; 2009 Jun; 17(11):3838-46. PubMed ID: 19433362
[TBL] [Abstract][Full Text] [Related]
15. Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida.
Ahmad A; Khan A; Manzoor N; Khan LA
Microb Pathog; 2010 Jan; 48(1):35-41. PubMed ID: 19835945
[TBL] [Abstract][Full Text] [Related]
16. New small-size peptides possessing antifungal activity.
Garibotto FM; Garro AD; Masman MF; Rodríguez AM; Luiten PG; Raimondi M; Zacchino SA; Somlai C; Penke B; Enriz RD
Bioorg Med Chem; 2010 Jan; 18(1):158-67. PubMed ID: 19959366
[TBL] [Abstract][Full Text] [Related]
17.
Chitty JL; Blake KL; Blundell RD; Koh YQAE; Thompson M; Robertson AAB; Butler MS; Cooper MA; Kappler U; Williams SJ; Kobe B; Fraser JA
J Biol Chem; 2017 Jul; 292(28):11829-11839. PubMed ID: 28559277
[TBL] [Abstract][Full Text] [Related]
18. Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide.
Malina A; Shai Y
Biochem J; 2005 Sep; 390(Pt 3):695-702. PubMed ID: 15907192
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of artemisinin derivatives.
Galal AM; Ross SA; Jacob M; ElSohly MA
J Nat Prod; 2005 Aug; 68(8):1274-6. PubMed ID: 16124777
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antifungal activity of benzofuran-5-ols.
Ryu CK; Song AL; Lee JY; Hong JA; Yoon JH; Kim A
Bioorg Med Chem Lett; 2010 Nov; 20(22):6777-80. PubMed ID: 20851600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
